37471 |
Oncology; Immunology |
Clinical advantage of targeted sequencing for unbiased tumor mutationa... |
J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 |
안진석 |
2020 |
37470 |
Respiratory System |
Characteristics of female lung cancer in Korea analysis of Korean Nati... |
J THORAC DIS 2020 10.21037/jtd-20-1671 |
안진석 |
2020 |
37469 |
Respiratory System |
Are there any ethnic differences in the efficacy and safety of immune ... |
J THORAC DIS 2020 10.21037/jtd.2019.08.29 |
안진석 |
2020 |
37468 |
Oncology |
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGF... |
ANN ONCOL 2020 10.1016/j.annonc.2020.06.017 |
안진석 |
2020 |
37467 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
박영석 |
2020 |
37466 |
Oncology |
Clinical and molecular distinctions in patients with refractory colon ... |
THER ADV MED ONCOL 2020 10.1177/1758835920965842 |
박영석 |
2020 |
37465 |
Oncology |
A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevaciz... |
CLIN COLORECTAL CANC 2020 10.1016/j.clcc.2020.03.004 |
박영석 |
2020 |
37464 |
Immunology |
Immunological Characteristics of Hyperprogressive Disease in Patients ... |
IMMUNE NETW 2020 10.4110/in.2020.20.e48 |
안명주 |
2020 |
37463 |
Multidisciplinary Sciences |
Regulatory -(FoxP3(+)) T cells and TGF-beta predict the response to an... |
SCI REP-UK 2020 10.1038/s41598-020-76130-1 |
안명주 |
2020 |
37462 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
안명주 |
2020 |